Literature DB >> 86113

Intracavitary doxorubicin in malignant effusions.

S D Desai, A Figueredo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 86113     DOI： 10.1016/s0140-6736(79)91282-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Management of malignant pleural effusions.

Authors:  F Grossi; M C Pennucci; L Tixi; M A Cafferata; A Ardizzoni
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  Plasma pharmacokinetics of adriamycin after intrapleural administration.

Authors:  S Eksborg; A Lindfors; B J Cedermark
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

3.  Intrapleural Corynebacterium parvum for malignant pleural effusions.

Authors:  R Felletti; C Ravazzoni
Journal:  Thorax       Date:  1983-01       Impact factor: 9.139

4.  Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.

Authors:  J W Millar; A M Hunter; N W Horne
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

5.  Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial.

Authors:  T Seto; S Ushijima; H Yamamoto; K Ito; J Araki; Y Inoue; H Semba; Y Ichinose
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.